These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 3257158)

  • 1. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K; Pellis NR; Kahan BD
    Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific chemoimmunotherapy of murine fibrosarcoma using tumor-specific transplantation antigen, cyclophosphamide, and interleukin-2.
    Naito K; Nomi S; Komichi H; Ueda Y; Yamagishi H; Oka T; Pellis NR; Kahan BD
    Cancer Detect Prev; 1992; 16(5-6):321-7. PubMed ID: 1361881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrasplenic administration of interleukin-2 to potentiate specific chemoimmunotherapy in tumor-bearing mice.
    Nomi S; Naito K; Kahan BD; Pellis NR
    Cancer Res; 1986 Nov; 46(11):5606-10. PubMed ID: 2875791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific chemoimmunotherapy in tumor-bearing mice with extracted antigen, cyclophosphamide, and intrasplenic administration of interleukin-2.
    Kahan BD; Nomi S; Pellis NR
    Cancer; 1986 Feb; 57(3):477-83. PubMed ID: 3484658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active specific immunotherapy with extracted tumor-specific transplantation antigen, cyclophosphamide, and adoptive transfer of tumor-specific cytotoxic T-cell clones.
    Naito K; Pellis NR; Kahan BD
    Cell Immunol; 1988 Jan; 111(1):216-34. PubMed ID: 3257414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retardation of postsurgical metastases with the use of extracted tumor-specific transplantation antigens and cyclophosphamide.
    Nomi S; Pellis NR; Kahan BD
    J Natl Cancer Inst; 1984 Oct; 73(4):943-50. PubMed ID: 6237215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumor gene expression after adoptive immunotherapy in a murine tumor model. Regulation of messenger RNA levels associated with the differential expansion of tumor-infiltrating lymphocytes.
    Evans R; Kamdar SJ; Duffy T; Edison L
    J Immunol; 1993 Jan; 150(1):177-84. PubMed ID: 8417123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
    Kahan BD; Tanaka T; Pellis NR
    J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
    Papa MZ; Mulé JJ; Rosenberg SA
    Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous intrasplenic interleukin-2 combined with antigen-specific chemoimmunotherapy.
    Naito K; Pellis NR; Kahan BD
    Arch Surg; 1986 Dec; 121(12):1415-20. PubMed ID: 3491596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapeutic effects of partially purified tumor-specific transplantation antigens on pulmonary metastases of a 3-methylcholanthrene-induced sarcoma in mice: a preliminary report.
    Tanaka T; Pellis NR; Kahan BD
    J Natl Cancer Inst; 1982 Nov; 69(5):1121-6. PubMed ID: 6957656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2.
    Ettinghausen SE; Rosenberg SA
    Cancer Res; 1986 Jun; 46(6):2784-92. PubMed ID: 3486038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ineffectiveness of adoptive chemoimmunotherapy with lymphokine-activated killer cells, interleukin-2, and cyclophosphamide on palpable intradermal murine bladder cancer.
    Lee K; O'Donnell RW; Cockett AT
    J Biol Response Mod; 1988 Feb; 7(1):43-53. PubMed ID: 3259620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells.
    Saarloos MN; Khoo NK; Lala PK
    Cancer Res; 1992 Dec; 52(23):6452-62. PubMed ID: 1423293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of chemotherapy and interleukin 2 in the therapy of mice with advanced pulmonary tumors.
    Papa MZ; Yang JC; Vetto JT; Shiloni E; Eisenthal A; Rosenberg SA
    Cancer Res; 1988 Jan; 48(1):122-9. PubMed ID: 3257159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor T cells can be induced to grow and survive long term in vivo without previous host immunosuppression.
    Chen W; Cheever MA
    J Immunol; 1994 May; 152(10):4767-74. PubMed ID: 8176202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active specific chemoimmunotherapy of lymph-node metastasis from a poorly immunogenic murine fibrosarcoma.
    Naito K; Oka T; Nomi S; Yamagishi H; Kahan BD
    Jpn J Cancer Res; 1989 Nov; 80(11):1119-26. PubMed ID: 2514172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterization of 1-butanol-extracted murine tumor-specific transplantation antigens.
    LeGrue SJ; Pellis NR; Riley LB; Kahan BD
    Cancer Res; 1985 Jul; 45(7):3164-72. PubMed ID: 2408745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.